Category: GE Healthcare
GE Healthcare is planning to move the U.S. headquarters for its life sciences division from New Jersey to Massachusetts.
Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter
Industry giant GE posts another lackluster quarter for its healthcare business with flat sales and profits for Q2 and low expectations for the rest of the year.
GE Healthcare (NYSE:GE) isn't terribly optimistic about its prospects for the rest of this year as its 2nd-quarter earnings report again shows softness in the U.S. dragging down total healthcare activity.
Medtech titan Medtronic has lured away a handful of GE Healthcare's top managers, leaving The General to do some reorganizing.
First U.S. Installs of Next-generation Breast Imaging Technology at Fairfax Radiological Consultants' Breast Diagnostic Imaging Center in D.C. and Phelps Memorial Hospital Center in NY.
FDA medtech regulators approve GE Healthcare's Invenia ultrasound mammography system, which can help detect cancers in women with dense breasts.
GE Healthcare (NYSE:GE) announced this week that it won FDA approval for its Invenia Automated Breast Ultrasound system, indicated to help doctors identify cancers in women with dense breast tissue.
Animal rights advocacy group PETA holds a tiny stake in several medtech companies, taking frequent advantage of its shareholder rights to push changes in the way device makers experiment on animals.
Animal rights activists have long raised concerns about some of the largest medical device companies, taking up minuscule stock holdings to gain access to shareholder meetings at a raft of medtech makers.